Zinc co-localizes with GABA and glycine in synapses in the lamprey spinal cord.
The presence of zinc in synaptic terminals in the lamprey spinal cord was examined utilizing a modification of the Timm's sulfide silver method and with the fluorescent marker 6-methoxy-8-quinolyl-p-toluenesulfonamide (TSQ). Axons labeled with a Timm's staining method were predominantly located in the lateral region of the dorsal column. This correlated with a maximum of TSQ fluorescence in this region of the spinal cord. Single labeled terminals accumulating Timm reaction product were also found throughout the gray matter and fiber tracts. At the ultrastructural level, zinc was located in a population of synaptic terminals that co-localized gamma-aminobutyric acid (GABA) and glycine. Possible effects of Zn2+ on neuronal activity were examined. In spinobulbar interneurons, which receive GABAergic input in the dorsal column, zinc potentiated responses to GABA application, but it did not affect responses to GABA in motoneurons. Responses in motoneurons to pressure application of glycine were also not affected by Zn2+. Zinc, however, potentiated monosynaptic glycinergic inhibitory postsynaptic potentials (IPSPs) evoked in motoneurons by inhibitory locomotor network interneurons and increased frequency, but not amplitude of spontaneous miniature IPSPs recorded in the presence of tetrodotoxin (TTX), suggesting presynaptic effects. Glutamate responses and the amplitude of monosynaptic excitatory postsynaptic potentials (EPSPs) in motoneurons were reduced by zinc. These effects appeared to be mediated largely postsynaptically through an effect on the N-methyl-D-aspartate (NMDA) component of the glutamatergic input. Our results thus show that free zinc is present in inhibitory synaptic terminals in the lamprey spinal cord, and that it may function as a modulator of inhibitory synaptic transmission.
Department of Anatomy, Histology, and Embryology, University Medical School of Debrecen, H-4012, Debrecen, Hungary.
A
A
Birinyi
D
D
Parker
M
M
Antal
O
O
Shupliakov
D000634:Aminoquinolines; D000818:Animals; D001369:Axons / Q000378:metabolism; D004396:Coloring Agents; D005260:Female; D005456:Fluorescent Dyes; D005973:Glutamine / Q000378:metabolism; D005998:Glycine / Q000378:metabolism*; D066298:In Vitro Techniques; D007798:Lampreys / Q000378:metabolism*; D008297:Male; D009043:Motor Activity / Q000502:physiology; D009411:Nerve Endings / Q000378:metabolism; D009415:Nerve Net / Q000187:drug effects / Q000502:physiology; D018030:Silver Compounds; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure; D013194:Staining and Labeling; D013569:Synapses / Q000378:metabolism*; D014018:Tissue Distribution; D014105:Tosyl Compounds; D015032:Zinc / Q000378:metabolism* / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000634:Aminoquinolines; D004396:Coloring Agents; D005456:Fluorescent Dyes; D018030:Silver Compounds; D014105:Tosyl Compounds; D005973:Glutamine; D005680:gamma-Aminobutyric Acid; C061730:N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide; C013251:silver sulfide; D015032:Zinc; D005998:Glycine